Meeting
2020 Genitourinary Cancers Symposium
Cost-effectiveness of radical cystectomy versus trimodality therapy for muscle invasive bladder cancer.
Authors
Nathan Suskovic
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
Nathan Suskovic , Ann C. Raldow , Trevor Joseph Royce , Angela Smith
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Other
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 575)
Abstract #
575
Poster Bd #
M12
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Radical cystectomy versus trimodality bladder-preserving therapy for muscle-invasive bladder cancer among elderly (80-84 years old) patients.
First Author: Shingo Hatakeyama
Poster
2023 ASCO Genitourinary Cancers Symposium
Oncological outcome of intraarterial chemotherapy combined with radiotherapy compared to radical cystectomy for patients with muscle invasive bladder cancer.
First Author: Katsuyoshi Higashijima
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
First Author: Vishnukamal Golla
Poster
2024 ASCO Genitourinary Cancers Symposium
Effects of perioperative chemotherapy on prognosis in muscle invasive bladder cancer treated with radical cystectomy.
First Author: Shingo Hatakeyama